07
Apr

Back in January, at the annual J.P. Morgan Healthcare Conference, across hotel lobbies and crowded hallways and standing-room-only cafes, one could hardly escape talk about the biotech IPO boom.

…read more

Source: Biotech’s breathless quarter of IPOs brings in $2.1B for R&D

    

0 No comments